← Securities 
◑ We're currently building out coverage for Swiss-listed stocks (SIX Exchange). Other markets will follow.
Basilea Pharmaceutica AG
CH0011432447 · BSLNSIX · 🇨🇭 CH · Healthcare · Stock
Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Allschwil, near Basel, focused on developing and commercializing drugs to treat serious and life-threatening bacterial and fungal infections as well as oncology indications. Its key marketed products include the antifungal agent isavuconazole and the antibiotic ceftobiprole. The company was spun off from Roche in 2000 and is listed on the SIX Swiss Exchange.
Last Dividend
5.00
CHF · 2013-04-11
5Y Growth
—
CAGR
Frequency
None
Years Paid
1
consecutive
Not Cut
—
consecutive yrs
Grown
—
consecutive yrs
Listings
| Exchange | Ticker | Currency |
|---|---|---|
| SIX primary | BSLN | CHF |
Annual Dividends
CHF 5.00
2013Annual dividend per share · 1 years of data
Dividend History
| Ex-Date ▼ | Pay-Date ▼ | Amount ▼ | Type ▼ |
|---|---|---|---|
| 11.04.2013 | 21.06.2013 | 5.00 CHF | Ordinary |